Which is Better to Assess Postoperative Complications in Patients Undergoing Laparoscopic Partial Nephrectomy?: Clavien-Dindo Classification Versus Comprehensive Complication Index.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Opertaion time
研究概览
简要总结
This study aims to compare the strength of the classical Clavien-Dindo classification system (CDC), which is a Likert scale analysis versus the comprehensive complication index (CCI), a new quantitative evaluation system, in patients undergoing laparoscopic partial nephrectomy (LPN).
详细描述
Prospectively collected data of sixty-two patients undergoing LPN with postoperative complications from November 2009 to August 2020 were evaluated retrospectively. Postoperative complications were classified according to the CDCs and calculated using the CCI calculator (https://www.assessurgery.com) quantitatively. Major complications were determined as ≥ grade 3 complications according to the CDC. The complexity of the renal mass was defined according to the RENAL nephrometry score. The cut-off value for CCI was analyzed by the ROC analysis technique. The significance level was taken as p<0.05.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients with complete data
- •patients with consent
- •Patients > 18 year-old
- •The surgeries performed by the surgeon EO
排除标准
- •Missing data
- •patients without consent
- •patients who underwent open or retroperitoneoscopic laparoscopic partial nephrectomy
结局指标
主要结局
Opertaion time
时间窗: during the surgery (minute)
From first trocar incision to closure of all incisions
Estimeted blood loss
时间窗: during the surgery (mL)
perioperative estimated blood loss
warm ischemia time
时间窗: during the surgery (minute)
Its starts when the renal artery and vein are controlled and it ends when reperfusion of the graft kidney starts on the back table
Postoperative complication
时间窗: up to 3 months, postoperatively
Abnormal clinical and laboratory findings that may be seen after surgery and require additional intervention, treatment, or follow-up
次要结局
未报告次要终点
研究者
Mehmet N. Mercimek, MD, FEBU
Associate professor, MD, FEBU
Samsun Liv Hospital